Aligos Therapeutics, Inc. (ALGS): SCHEDULE 13D filed Jun 24, 2026

Form type

SCHEDULE 13D

Filing date

Jun 24, 2026

Accession number

0001193125-26-281134

Filer

Aligos Therapeutics, Inc. (CIK 1799448)